The Challenge of Change - Managing Excipients Control
Colorcon
22-Sep-2011 - in-PharmaTechnologist presents its round-up of the latest appointments in the pharmaceutical industry, including news from Silence Therapeutics, InSite Vision, and Zafgen.
21-Sep-2011 - US drug maker Isis Pharmaceuticals has opened a new R&D centre in Carlsbad, California designed to forge closer interdisciplinary bonds.
15-Sep-2011 - in-PharmaTechnologist.com presents its round-up of the latest pharmaceutical industry appointments, including news from Okairos, Immunovaccine, and SteadyMed.
08-Sep-2011 - in-PharmaTechnologist presents its round-ups of the latest pharmaceutical appointments, including news from Alegeta, Zealand, Otexs and TYRX.
05-Sep-2011 - The US FDA are pushing to extend its approval process by two-months.
01-Sep-2011 - in-Pharma Technologist brings you its round-up of the new appointments within the pharmaceutical industry, including news from Merck KGaA, Sanofi Pasteur, H&P and CADTH.
31-Aug-2011 - US drug giant Pfizer is to sell its plant in Henrico County, Virginia to Luxembourg-headquartered manufacturer Fareva.
30-Aug-2011 - Drug manufacturers on the US’ east coast seem to have survived Hurricane Irene unscathed, with only a few incidents of damage reported so far.
29-Aug-2011 - Tanzanian Pharmaceutical Industries (TPI) is set to open the doors to a new anti-retroviral drugs (ARVs) manufacturing plant.
25-Aug-2011 - in-PharmaTechnologist presents its latest round-up of the movers and shakers within the pharmaceutical industry, including appointments from AAPS, SurModics, Diamedica, and Sirona Biochem.
24-Aug-2011 - Drug counterfeiters are using the Caribbean as a transport hub to ship fake pharmaceutical around the world according to the Antigua Pharmaceutical Society.
23-Aug-2011 - Australia’s TGA will begin a series of workshops to help drugmakers navigate its revised guidance of biologics.
18-Aug-2011 - in-PharmaTechnologist.com presents its round-up of executive moves within the pharma sector, including appointments from Unilife, Aceto and Cangene.
18-Aug-2011 - Promega will start work on a US manufacturing facility later this month in a project expected to create 100 jobs over the next five years.
17-Aug-2011 - Pfizer’s former R&D facility in Sandwich, Kent has been declared an ‘enterprise zone’ by the UK government
11-Aug-2011 - Close to two-thirds of biopharm companies plan to increase reliance on 3PL providers and global manufacturers in coming years, a survey found.
10-Aug-2011 - In-PharmaTechnologistpresents its latest round-up of executive moves in the pharma industry, including appointments at Akrimax, Vernalis, Sanofi and Pregis.
03-Aug-2011 - The number of in-transit pharmaceutical robberies in the US has been sliced by almost half since last year, according to FreightWatch’s Biannual Cargo Theft Report.
03-Aug-2011 - The US FDA is on track to approve more drugs in 2011 than it did last year but industry and regulators need to do more to sustain the improvement according to a new study.
01-Aug-2011 - US drugmaker Merck & Co announced plans to reduce its workforce by 13 percent, or 13,000 employees, in a bid to cut costs and focus its efforts in emerging markets.
01-Aug-2011 - in-PharmaTechnologist.com presents its latest round up of executive moves in the pharma sector, including appointments at Sanofi, GlaxoSmithKline, Croda and Provectus.
28-Jul-2011 - Network pharmacology specialist E-Therapeutics has restarted its drug discovery unit in response to improving economic climate and investor demand.
26-Jul-2011 - in-PharmaTechnologist.com presents its latest round up of executive moves in the pharma sector, including appointments at Sanofi, Amylin, Lophius Biosciences, Lophius, Adventrx, BioSante and Medicure.
26-Jul-2011 - Blue Chip Patient Recruitment says the future of patient sourcing for clinical trials lies in social media.
26-Jul-2011 - The Australian Therapeutic Goods Administration (TGA) should be more transparent about its market authorisation decisions, monitoring and compliance practices according to a panel set up to examine the regulators inner workings.